Arrowhead Research Soars After Acquiring Novartis' RNAi Portfolio

By: via Benzinga
Arrowhead Research Corp (NASDAQ: ARWR) was trading higher on Thursday after the announcement that they acquired Novartis' (NYSE: ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.